CorVel Corporation (CRVL)
NASDAQ: CRVL
· Real-Time Price · USD
110.19
0.00 (0.00%)
At close: May 15, 2025, 3:59 PM
110.03
-0.14%
After-hours: May 15, 2025, 04:05 PM EDT
CorVel Revenue Breakdown
| Period Ending | Mar 31, 2024 | Mar 31, 2022 | Mar 31, 2021 | Mar 31, 2020 | Mar 31, 2019 |
|---|---|---|---|---|---|
| Network Solutions Services Revenue | 265.32M | 222.18M | 183.79M | 205.41M | 227.54M |
| Network Solutions Services Revenue Growth | +19.41% | +20.89% | -10.53% | -9.73% | n/a |
| Patient Management Services Revenue | 530M | 424.05M | 368.85M | 386.81M | 368.2M |
| Patient Management Services Revenue Growth | +24.98% | +14.96% | -4.64% | +5.06% | n/a |
Operating Expense Breakdown
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 22.06M | 22.08M | 13.39M | 14.12M | 13.05M | 19.54M | 16.45M | 19.36M | 18.13M | 17.55M | 18.67M | 16.79M | 17.51M | 16.66M | 16.64M | 16.37M | 16.94M | 15.56M | 15.59M | 15.87M | 17M | 16.59M | 15.75M | 16.46M | 15.8M | 15.09M | 15.94M | 15.55M | 15.5M | 13.67M | 14.63M | 15M | 14.13M | 14.64M | 13.46M | 15.81M | 14.5M | 13.21M | 14.96M | 13.62M |
| Selling, General, and Administrative Revenue Growth | -0.09% | +64.84% | -5.16% | +8.19% | -33.19% | +18.77% | -15.02% | +6.79% | +3.30% | -6.01% | +11.18% | -4.07% | +5.09% | +0.08% | +1.70% | -3.37% | +8.85% | -0.16% | -1.76% | -6.68% | +2.45% | +5.34% | -4.31% | +4.17% | +4.70% | -5.29% | +2.46% | +0.37% | +13.36% | -6.56% | -2.50% | +6.16% | -3.48% | +8.79% | -14.87% | +9.04% | +9.78% | -11.72% | +9.89% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales and Marketing Revenue | 20.92M | n/a | 19.77M | -6.68M | 12.71M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales and Marketing Revenue Growth | n/a | -100.00% | -395.75% | -152.58% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |